Bayer to sell its diabetes unit to streamline medtech offering further?
This article was originally published in Clinica
Executive Summary
Bayer is looking to offload its diabetes care unit and is in talks with potential buyers, according to unconfirmed media reports. Financial Times Deutschland and Reuters both reported that Bayer was selling the unit as it offers few synergies with the rest of its healthcare portfolio.